Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07082244 · ClinicalTrials.gov registry record · NA
Implant Phenotype Modification Via GBR and ADM
A NA study of Horizontal Ridge Deficiency, sponsored by University of Michigan.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT07082244: Recruiting NA study of Horizontal Ridge Deficiency, sponsored by University of Michigan.
NCT07082244 is a NA study of Horizontal Ridge Deficiency that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07082244, a NA study of Horizontal Ridge Deficiency, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Single implant sites with bone loss can often be managed by bone grafting alone. The purpose of this study is to determine whether putting a soft tissue graft substitute over the bone graft will provide an increased benefit for improving the health, appearance, and stability of the bone and gums surrounding the implant.
Primary Outcome
Radiographic changes of bone level in mm based on cone-beam computed tomography
Conditions Studied
Interventions
- PROCEDURE Dental implant placement
- PROCEDURE Guided bone regeneration with collagen membrane
- PROCEDURE Guided bone regeneration with acellular dermal matrix.
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-06-01 |
| Est. Completion | 2026-09-01 |
| Phase | NA |
What NCT07082244 shows while recruiting
NCT07082244 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Horizontal Ridge Deficiency appearing as the primary indexed condition, and to 3 interventions - of which Dental implant placement is the first listed.
NCT07082244 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT07082244 about?
NCT07082244 is a clinical study titled "Implant Phenotype Modification Via GBR and ADM". Single implant sites with bone loss can often be managed by bone grafting alone. The purpose of this study is to determine whether putting a soft tissue graft substitute over the bone graft will provide an increased benefit for improving the health, appearance, and stability of the bone and gums sur...
What is the current status of trial NCT07082244?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-06-01. Estimated completion is 2026-09-01.
What conditions does trial NCT07082244 study?
This clinical trial studies the following conditions: Horizontal Ridge Deficiency.
What interventions are being tested in trial NCT07082244?
The interventions under investigation include: Dental implant placement (PROCEDURE), Guided bone regeneration with collagen membrane (PROCEDURE), Guided bone regeneration with acellular dermal matrix. (PROCEDURE).
Who is sponsoring clinical trial NCT07082244?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07082244 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07082244's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI